Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-112,200
Closed -$5.46M 117
2017
Q2
$5.49M Sell
112,200
-112,200
-50% -$5.2M 0.1% 56
2017
Q1
$10.6M Buy
+224,400
New +$10.7M 0.23% 38
2016
Q4
Sell
-196,350
Closed -$9.01M 97
2016
Q3
$7.78M Sell
196,350
-84,150
-30% -$3.16M 0.15% 40
2016
Q2
$9.96M Buy
280,500
+16,830
+6% +$656K 0.21% 33
2016
Q1
$10.3M Buy
+263,670
New +$9.86M 0.2% 33
2015
Q2
Sell
-448,800
Closed -$21.3M 83
2015
Q1
$20.2M Hold
448,800
0.93% 27
2014
Q4
$21.6M Buy
+448,800
New +$21.3M 0.76% 29
2013
Q3
Sell
-448,800
Closed -$18.3M 99
2013
Q2
$18.3M Buy
+448,800
New +$16.5M 0.58% 25

Other funds holding MET

Artal Group's MET Position: Q3 2017 in Review

Artal Group sold out of MetLife (MET) in Q3 2017, closing a stake of 112,200 shares — an estimated $5.46M sold.

Artal Group first reported a position in MET in Q2 2013 and held it in 8 quarters. The position peaked at $21.6M in Q4 2014. 986 funds tracked by Wall St. Rank hold MET as of Q3 2017.

  • Artal Group reported no remaining MetLife position as of Q3 2017 after selling out during the quarter.
  • Artal Group sold 112,200 MetLife shares in Q3 2017, an estimated $5.46M.
  • Artal Group first reported a position in MetLife in Q2 2013 and held it in 8 quarters.
  • Artal Group's MetLife position peaked at $21.6M in Q4 2014.
  • 986 funds tracked by Wall St. Rank held MetLife as of Q3 2017.

Based on Artal Group's 13F filing for Q3 2017, filed 8 Nov 2017.